Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term results of thumb carpometacarpal joint arthrodesis.

Archives of orthopaedic and trauma surgery·2026
Same author

Factors associated with variation in treatment of the distal radioulnar joint after plate fixation of distal radial fractures.

The Journal of hand surgery, European volume·2026
Same author

Restoration of CPAK type in total knee arthroplasty does not lead to superior clinical outcome: A study based on arthroplasty registry data.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2026
Same author

Combined trochleoplasty and medial patellofemoral ligament reconstruction reduces patellar height.

Journal of experimental orthopaedics·2026
Same author

No significant side-to-side differences in retropatellar load distribution using more than 7.5 years after isolated MPFL reconstruction: A CT-osteoabsorptiometry pilot study in nine patients.

Journal of experimental orthopaedics·2026
Same author

Rerupture after flexor tendon repair of the hand and wrist: a retrospective risk factor analysis.

Archives of orthopaedic and trauma surgery·2026

Related Experiment Videos

Transmyocardial revascularization: peril and potential.

Jordan Tasse1, Rohit Arora

  • 1Department of Cardiology, Chicago Medical School, 3001 Green Bay Road, Chicago, IL 60064, USA.

Journal of Cardiovascular Pharmacology and Therapeutics
|May 15, 2007
PubMed
Summary

Transmyocardial laser revascularization (TMLR) and percutaneous myocardial revascularization (PMR) improve angina class in refractory cases. However, their definitive impact on survival and cardiac function requires further investigation.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Minimally Invasive Cardiac Procedures

Background:

  • Chronic angina pectoris refractory to medical therapy poses a significant clinical challenge.
  • Transmyocardial laser revascularization (TMLR) and percutaneous myocardial revascularization (PMR) offer alternative treatment options for eligible patients.
  • PMR is a less-invasive catheter-based adaptation of TMLR.

Purpose of the Study:

  • To summarize and analyze the results of prospective randomized clinical trials comparing TMLR and PMR.
  • To explain the proposed mechanisms of action for TMLR.
  • To discuss the current clinical role of TMLR based on existing evidence.

Main Methods:

  • Review of six prospective randomized clinical trials for TMLR.
  • Review of five prospective randomized clinical trials for PMR.
  • Analysis of reported outcomes including angina class, survival, exercise tolerance, ejection fraction, and myocardial perfusion.

Main Results:

  • All TMLR trials demonstrated significant improvement in angina class.
  • Four out of five PMR trials showed significant improvement in angina class.
  • Evidence for improved survival, exercise tolerance, ejection fraction, and myocardial perfusion was less definitive for both TMLR and PMR.
  • TMLR carries potential risks of morbidity and mortality.

Conclusions:

  • Both TMLR and PMR can effectively improve angina symptoms in patients with refractory chronic angina.
  • The definitive benefits of these procedures on long-term survival and cardiac function remain uncertain.
  • The current role of TMLR in patient treatment requires careful consideration of the existing evidence and potential risks.